Immediate Impact

1 by Nobel laureates 6 standout
Sub-graph 1 of 3

Citing Papers

mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
2023 Standout
2 intermediate papers

Works of Robert P. Lavan being referenced

Rationale and support for a One Health program for canine vaccination as the most cost-effective means of controlling zoonotic rabies in endemic settings
2017

Author Peers

Author Last Decade Papers Cites
Robert P. Lavan 105 110 43 53 18 228
Minna Nylund 109 84 54 16 14 291
Muhammad Umair Aziz 166 110 61 47 22 264
Paola Prati 112 90 72 35 25 289
R.G. Stevenson 75 85 104 32 23 288
Emilio Rendón‐Franco 150 99 65 25 38 277
James M. Crum 111 73 45 14 17 282
Aarón Martín-Alonso 120 117 15 17 15 270
Hüseyin Voyvoda 92 105 25 14 28 298
R.D. Bigalke 238 76 54 26 18 292
Sonja Radojičić 49 81 59 57 34 270

All Works

Loading papers...

Rankless by CCL
2026